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Abstract
Introduction:  The  Rhinitis  Control  Assessment  Test  (RCAT)  is  a  simple  self-administered  ques-
tionnaire  developed  to  assess  control  of  rhinitis.
Objectives:  Translate  into  Brazilian  Portuguese  and  validate  the  RCAT.
Methods:  The  RCAT  was  translated  into  Portuguese  by  two  translators  and  subsequently  back-
translated  into  English.  It  was  then  applied  to  141  adolescents  with  allergic  rhinitis.
Results:  The  internal  consistency  of  the  RCAT  was  0.73.  The  questionnaire  scores  showed  sig-
niﬁcant correlation  with  total  nasal  and  extra-nasal  symptom  scores  and  nasal  peak  inspiratory
ﬂow (r:  −0.73,  −0.58  and  0.52,  respectively;  p  <  0.001)  and  were  signiﬁcantly  different  when
divided  by  physician  global  assessment  and  total  nasal  symptom  score  severity.  Cutoff  points
between 22  and  24  had  the  higher  areas  under  the  ROC  curve  to  identify  patients  with  rhinitis
control.  Total  nasal  and  extra-nasal  symptom  scores  were  signiﬁcantly  different  when  a  cutoff
point of  22  was  used  (median:  4.0  vs.  8.0  and  2.0  vs.  5.0;  p  <  0.001).
Conclusions:  The  Brazilian  Portuguese  version  of  the  RCAT  was  shown  to  be  a  valid  and  discrim-
inant tool  to  identify  patients  with  controlled  and  uncontrolled  allergic  rhinitis.
© 2016  Associac¸a˜o  Brasileira  de  Otorrinolaringologia  e  Cirurgia  Ce´rvico-Facial.  Published
by Elsevier  Editora  Ltda.  This  is  an  open  access  article  under  the  CC  BY  license  (http://
creativecommons.org/licenses/by/4.0/).PALAVRAS-CHAVE Traduc¸ão  para  o  português  e  validac¸ão  do  questionário  de  controle  da  rinite  Rhinitis
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Resumo
Introduc¸ão:  O  Rhinitis  Control  Assessment  Test  (RCAT)  é  um  questionário  simples  e
autoaplicável  desenvolvido  para  avaliar  o  controle  da  rinite. Please cite this article as: Fernandes PH, Matsumoto F, Solé D, Wandalsen GF. Translation into Portuguese and validation of the Rhinitis
ontrol Assessment Test (RCAT) questionnaire. Braz J Otorhinolaryngol. 2016;82:674--9.
∗ Corresponding author.
E-mail: gfwandalsen@uol.com.br (G.F. Wandalsen).
ttp://dx.doi.org/10.1016/j.bjorl.2015.12.011
808-8694/© 2016 Associac¸a˜o Brasileira de Otorrinolaringologia e Cirurgia Ce´rvico-Facial. Published by Elsevier Editora Ltda. This is an open
ccess article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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Objetivos:  Traduzir  para  o  Português  validar  o  RCAT.
Método:  A  traduc¸ão  do  RCAT  foi  feita  por  dois  tradutores  com  posterior  versão  para  a  Língua
Inglesa.  O  RCAT  foi  então  aplicado  de  forma  transversal  a  141  adolescentes  com  rinite  alérgica.
Resultados:  A  consistência  interna  do  RCAT  foi  0,73.  As  notas  totais  do  questionário  se  correla-
cionaram  signiﬁcantemente  com  os  escores  de  sintomas  nasais  e  extra-nasais  e  pico  de  ﬂuxo
inspiratório  nasal  (r:  -0,73,  -0,58  e  0,52,  respectivamente;  p  <  0,001)  e  foram  signiﬁcantemente
diferentes  quando  separadas  pela  opinião  médica  sobre  o  controle  da  rinite  e  pela  gravidade
dos sintomas  nasais.  Os  pontos  de  corte  entre  22  e  24  foram  os  com  maiores  áreas  sob  a  curva
ROC para  deﬁnic¸ão  do  controle  da  rinite.  Os  escores  de  sintomas  nasais  e  extra-nasais  foram
signiﬁcantemente  diferentes  quando  os  pacientes  foram  separados  pelo  ponto  de  corte  de  22
(medianas de  4,0  vs.  8,0  e  2,0  vs.  5,0;  p  <  0,001).
Conclusões:  A  versão  em  Português  do  RCAT  se  mostrou  uma  ferramenta  válida  e  com  bom
poder discriminativo  para  separar  pacientes  com  rinite  alérgica  controlada  e  não  controlada.
© 2016  Associac¸a˜o  Brasileira  de  Otorrinolaringologia  e  Cirurgia  Ce´rvico-Facial.  Publicado
por Elsevier  Editora  Ltda.  Este e´  um  artigo  Open  Access  sob  uma  licenc¸a  CC  BY  (http://
creativecommons.org/licenses/by/4.0/).
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(Introduction
Allergic  rhinitis  is  the  most  prevalent  allergic  disease  in
Brazil.  Brazilian  data,  obtained  through  the  International
Study  of  Asthma  and  Allergies  in  Childhood  (ISAAC)  study
showed  that  the  prevalence  of  rhinitis  in  children  and  ado-
lescents  ranges  from  10%  to  47%,  depending  on  the  deﬁnition
used  and  the  age  group  studied.1 Traditionally,  allergic  rhini-
tis  was  considered  a  disease  of  minor  importance  due  to
its  low  morbidity  and  mortality.  In  the  last  decade,  the
importance  of  allergic  rhinitis  has  been  increasingly  high-
lighted,  mainly  because  of  its  complications,  high  cost,
negative  impact  on  quality  of  life,  and  association  with  other
diseases.2,3
Currently,  the  recommendations  for  the  drug  manage-
ment  of  allergic  rhinitis  are  based  on  the  classiﬁcation  of  the
disease  severity  and  persistence  of  symptoms.2 These  rec-
ommendations  are  easily  applicable  to  patients  not  under
current  treatment  at  the  beginning  of  follow-up,  but  are
less  applicable  to  evaluate  changes  over  time  and  cannot
measure  response  to  treatment.  Managing  the  disease  by
controlling  the  magnitude  of  its  symptoms  has  been  demon-
strated  to  be  useful  and  practical  in  asthma,  and  is  currently
the  recommended  form  of  management.4
A  few  years  ago,  a  questionnaire  was  developed  to  assess
the  level  of  rhinitis  control  called  Rhinitis  Control  Assess-
ment  Test  (RCAT).5,6 This  questionnaire,  developed  in  the
English  language,  consists  of  six  questions  with  ﬁve  answer
levels  that  comprise  a  total  score.  The  questions  refer  to
the  previous  week  and  address  symptoms  (nasal  congestion,
sneezing,  and  eye  tearing),  interference  with  sleep  and  daily
activities,  and  the  individual’s  personal  opinion  about  symp-
tom  control.5,6
Evaluation  of  the  original  version  of  RCAT  showed  that  the
questionnaire  is  valid  and  reliable  and  can  be  used  for  rapid
screening  of  patients  with  difﬁcult-to-control  rhinitis  symp-
toms  and  as  an  additional  tool  in  the  clinical  management
of  rhinitis.6
This  study  aimed  to  translate  and  adapt  the  RCAT  ques-
tionnaire  into  Portuguese  language  (Brazilian  culture),  and
to  validate  that  translated  version.
m
r
p
ﬁethods
he  RCAT  questionnaire  translation  into  Portuguese  was
erformed  by  two  different  translators  with  a  subsequent
ack-translation  to  English  and  ﬁnal  conciliation  of  the  ver-
ions.  The  resulting  version  was  then  applied  to  ten  patients
ith  allergic  rhinitis  (older  than  11  years  of  age)  to  evaluate
ts  intellection.
The  validation  of  the  translated  version  of  the  ques-
ionnaire  was  carried  out  as  an  observational,  descriptive,
nalytical,  and  cross-sectional  assessment,  applied  to
atients  in  a  referral  allergy  outpatient  clinic.  Adolescents
12--18  years,  both  genders),  with  documented  diagnosis  of
llergic  rhinitis  for  at  least  six  months  were  invited  to  par-
icipate  in  the  questionnaire  validation.  Only  patients  with
roven  allergic  sensitization  to  at  least  one  inhaled  allergen,
emonstrated  by  skin  prick  test  or  speciﬁc  serum  IgE  tests
erformed  in  the  last  two  years  participated  in  the  study.
Those  with  a  history  of  symptoms  consistent  with  infec-
ious  diseases  of  the  upper  airways  in  the  last  15  days,  as  well
s  those  with  neuropathy,  cognitive  deﬁcits,  and  structural
hanges  of  the  upper  airways  (clinical  assessment)  were  not
nvited  to  participate  in  the  study.
The  patients  answered  the  translated  version  of  RCAT,
hich  consisted  of  six  questions  related  to  symptoms  expe-
ienced  in  the  previous  week.  Each  question  received  scores
anging  from  1  to  5  points  according  to  the  frequency  of
eporting,  with  score  5  for  ‘‘never,’’  4  for  ‘‘rarely,’’  3  for
‘sometimes,’’  2  for  ‘‘often,’’  and  1  for  ‘‘very  often’’.  The
nal  score  (RCATT),  given  by  the  sum  of  all  questions,  could
ange  from  six  to  30  points.6 According  to  the  total  score
btained,  patients  were  divided  into  two  groups  accord-
ng  to  the  original  questionnaire  validation:  controlled  (≥22
oints)  and  uncontrolled  (<22  points).6
Additionally,  patients  were  evaluated  through  the  Nasal
ymptom  Score  (NSS)  and  the  Extra-Nasal  Symptom  Score
ENSS).  The  NSS  was  related  to  the  week  prior  to  the  assess-
ent,  assigned  by  the  patient  (ranging  from  0  to  3)  for
hinorrhea,  nasal  obstruction,  nasal  itching,  sneezing,  and
ostnasal  drip,  and  calculated  by  adding  the  scores  for  the
ve  symptoms.  The  severity  of  the  clinical  condition  was
6 Fernandes  PH  et  al.
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Durante a última semana, com que frequência você apresentou obstrução
nasal?
1)
2)
3)
4)
5)
6)
Nunca
5 4 3 2 1
5 4 3 2 1
5 4 3 2 1
5 4 3 2 1
5 4 3 2 1
5 4 3 2 1
Raramente As vezes Frequentemente Muitofrequentemente
Nunca Raramente As vezes Frequentemente Muitofrequentemente
Nunca Raramente As vezes Frequentemente Muitofrequentemente
Nunca
Completamente
Raramente As vezes Frequentemente Muitofrequentemente
Nada
Nada
Pouco
Pouco
Ocasionalmente
Ocasionalmente
Muito
Muito
Todo o tempo
Durante a última semana, com que frequ ência você espirrou?
Durante a última semana, com que frequência seus olhos lacrimejaram?
Durante a última semana, quanto seus sintomas nasais ou alérgicos
interferiram com o seu sono?
Durante a última semana, com que frequência você evitou alguma atividade
(por exemplo, visitar uma case com gato ou cachorro) devido aos seus
sintomas nasais ou de outras alergias?
Durante a última semana, quanto seus sintomas nasais ou alérgicos 
estiveram controlados?
Figure  1  Translated  version  of  the  Rhinitis  Control  Assess-
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lassiﬁed  according  to  the  NSS,  being  considered  mild  (NSS
--5),  moderate  (NSS  6--10),  or  severe  (NSS  11--15).6 The
NSS,  also  related  to  the  week  prior  to  the  assessment,  was
easured  by  addressing  the  following  symptoms:  eye  tear-
ng,  eye  itching,  pharyngeal  pruritus,  and  ocular  hyperemia,
hich  were  scored  according  to  the  NSS  (maximum  12).
An  objective  assessment  of  nasal  function  was  performed
y  measuring  the  Peak  Nasal  Inspiratory  Flow  (PNIF)  using
peciﬁc  equipment  (In-Check®;  Clement  Clarke,  England).
uring  the  procedure,  patients  were  instructed  to  perform
eep  inspirations  up  to  total  lung  capacity,  keeping  the  lips
ightly  closed.  The  maximum  ﬂow  rate  was  read  by  the  cur-
or  in  liters  per  minute.  At  least  three  measurements  were
erformed  and  the  best  measurement  among  the  three  was
ecorded,  with  a  variation  of  less  than  10%.7
All  patients  underwent  medical  assessment  before  the
uestionnaires  were  applied,  in  which  any  medications  being
sed  and  associated  comorbidities  were  recorded.  Medical
pinion  was  requested  about  the  patients’  nasal  symp-
om  control,  and  the  physician’s  subjective  classiﬁcation
oted  as  controlled,  partially  controlled,  or  uncontrolled.
imilarly,  the  physician  reported  his/her  opinion  regarding
dherence  or  not  to  the  proposed  treatment  in  previous
onsultations,  according  to  data  obtained  at  the  interview.
The  study  was  approved  by  the  Research  Ethics  Commit-
ee  of  the  institution  (protocol  n.  282867)  and  an  informed
onsent  form  was  obtained  from  all  participants  and  their
arents/guardians.
Sample  size  calculation  was  performed  based  on  the
orrelation  coefﬁcients  found  between  the  scores  of  the
riginal  questionnaire  and  the  clinical  scores  ranging  from
.3  to  0.6.6 Thus,  estimating  a  minimum  r of  0.3,  at  least  116
atients  would  be  necessary  to  ensure  signiﬁcant  correlation
ith  a  power  of  95%  and  p  =  0.05.
The  constructive  validation  of  the  translated  version  of
CAT  was  performed  by  comparing  the  scores  obtained  with
he  NSS,  ENSS,  and  PNIF,  using  Spearman’s  correlation  test.
he  discriminatory  capacity  was  assessed  by  comparing  the
CAT  scores  according  to  the  medical  classiﬁcation  of  rhinitis
ontrol  and  severity  of  nasal  symptoms  using  non-parametric
ests  (Mann--Whitney  and  Kruskal--Wallis).  The  internal  con-
istency  of  RCAT  was  assessed  by  Cronbach’s  alpha.  Receiver
perating  characteristic  curves  were  constructed  to  estab-
ish  cutoff  scores,  according  to  the  medical  opinion  about
isease  control  (controlled  rhinitis  vs.  partially  controlled
nd  uncontrolled  rhinitis).
esults
he  RCAT  version  that  was  translated  into  Portuguese
Brazilian  culture)  is  shown  in  Fig.  1.  There  were  no
igniﬁcant  differences  between  the  two  translations  into
ortuguese,  and  therefore  the  ﬁnal  consolidation  of  the
ranslated  RCAT  and  the  English  version  did  not  result  in  any
hanges  to  the  original  tool.  At  the  initial  assessment,  the
uestionnaire  was  easily  understood  by  the  adolescents  and
t  was  quickly  completed.A  total  of  141  adolescents  aged  between  12  and  18  years
median  13  years),  participated  in  the  validation  phase,
f  whom  the  majority  was  male  (74%)  and  white  (47%).
he  median  of  years  with  nasal  symptoms  was  8  years
o
a
s
tent  Test  (RCAT)  into  the  Portuguese  language  (Brazilian
ulture).
interquartile  range  [IQR]:  5--11  years).  All  patients
ttended  school  and  were  literate.  The  internal  consistency
f  the  questionnaire  measured  by  Cronbach’s  ˛  was  0.73.
Regarding  the  medical  opinion  about  the  control  of
atients’  nasal  symptoms,  53  (38%)  were  classiﬁed  as  con-
rolled,  51  (36%)  as  partially  controlled,  and  37  (26%)  as
ncontrolled.  According  to  the  medical  opinion,  106  (75%)
atients  were  considered  adherent  and  35  (25%)  were  non-
dherent  to  treatment.
The  NSS  median  was  5  (IQR:  3--8),  the  ENSS  median
as  3  (IQR:  1--6),  and  PNIF  median  was  130  L/min  (IQR:
00--150  L/min).  According  to  the  NSS  score,  mild  symptoms
ere  observed  in  78  patients  (55%),  moderate  in  50  (36%),
nd  severe  in  13  (9%).  The  RCAT  scores  ranged  between  10
nd  30,  with  a  median  of  22  (IQR:  19--26).
The  correlation  coefﬁcients  of  RCAT  with  the  NSS,
NSS  and  PNIF  were  respectively  −0.73;  −0.58;  and  0.52
p  <  0.001).  Individual  values  are  shown  in  Fig.  2.
The  RCAT  scores  were  signiﬁcantly  different  (p  <  0.001)
hen  separated  by  the  medical  opinion  about  nasal  symptom
ontrol  (Fig.  3) and  nasal  symptom  severity  (Fig.  4).
Sensitivity,  speciﬁcity,  and  area  under  the  ROC  curve  of
CAT  for  different  cutoff  points  to  deﬁne  rhinitis  control
re  shown  in  Table  1. The  cutoff  point  of  22,  deﬁned  in  the
riginal  questionnaire  validation,  showed  a  sensitivity  of  89%
nd  speciﬁcity  of  66%  in  the  deﬁnition  of  allergic  rhinitis
ymptom  control.  The  cutoff  scores  with  larger  areas  under
he  ROC  curve  were  23  and  24  points.
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Figure  2  Correlation  between  total  Rhinitis  Control  Assessment  Test  (RCAT)  scores  (RCATT)  and  Nasal  Symptom  Score  (NSS),
Extra-Nasal Symptom  Score  (ENSS),  and  Peak  Nasal  Inspiratory  Flow  (PNIF)  values.
Table  1  Sensitivity,  speciﬁcity,  and  area  under  the  receiver  operating  characteristic  (ROC)  curve  of  different  Rhinitis  Control
Assessment  Test  (RCAT)  cutoffs  to  deﬁne  rhinitis  control.
Cutoff  point  Sensitivity  (%)  Speciﬁcity  (%)  Area  under  the  ROC  curve
≥25  60.4  87.5  0.739
≥24 79.2  79.5  0.794
≥23 84.9  73.9  0.794
≥22 88.7  65.9  0.773
≥21 94.3  56.8  0.756
≥20 94.3  42.0  0.682
≥19 96.2  35.2  0.657
30
25
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R
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10
Figure  3  Total  score  values  of  Rhinitis  Control  Assessment
Test (RCAT)  discriminated  by  the  medical  opinion  about  the
control  of  nasal  symptoms  as  controlled  (white),  partially  con-
trolled (light  gray),  and  uncontrolled  (dark  gray).
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Figure  4  Total  score  values  of  Rhinitis  Control  Assessment
Test (RCAT)  discriminated  by  the  severity  of  nasal  symptoms
as mild  (white),  moderate  (light  gray),  and  severe  (dark  gray).
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Figure  5  Score  values  of  Nasal  Symptom  Score  (NSS),  Extra-Nasal  Symptom  Score  (ENSS)  and  Peak  Nasal  Inspiratory  Flow  (PNIF)
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white; RCATT  <22).
Applying  the  RCAT  cutoff  score  of  22  points,  77  patients
ere  deﬁned  as  controlled  and  64  as  uncontrolled.  The  NSS,
NSS,  and  PNIF  were  signiﬁcantly  different  between  these
wo  groups  (p  <  0.001)  with  medians  of,  respectively:  4.0  vs.
.0;  2.0  vs.  5.0;  and  150  L/min  vs.  100  L/min  (Fig.  5).
iscussion
ools  or  scores  have  frequently  been  used  in  the  manage-
ent  of  several  chronic  diseases,  such  as  asthma  and  chronic
ives.8,9 These  tools  can  have  many  applications  and  are
sed  both  to  screen  patients  in  primary  care  settings  and  to
ssist  in  medical  management  by  specialists.
Several  questionnaires  are  available  for  the  assessment
f  patients  with  nasal  diseases.  Among  these,  those  devel-
ped  to  assess  the  quality  of  life  in  patients  with  speciﬁc
iseases,  such  as  allergic  rhinoconjunctivitis10 and  chronic
hinosinusitis/nasal  polyposis  (SNOT-22),11 translated  and
alidated  into  the  Portuguese  language  (Brazilian  culture),
re  noteworthy.12,13 Other  questionnaires  assess  certain
ymptoms,  such  as  nasal  obstruction  (NOSE),14 or  a  combi-
ation  of  diseases,  such  as  rhinitis  and  asthma.15,16 To  the
est  of  the  present  authors’  knowledge  and  that  of  other
uthors,5 the  RCAT  was  the  ﬁrst  tool  of  this  type  to  be
eveloped  for  the  assessment  of  allergic  rhinitis  control.
The  RCAT  was  developed  as  a  simple,  concise,  and  self-
dministered  tool  to  assess  rhinitis  control.5 The  items  in
c
i
e Rhinitis  Control  Assessment  Test  (RCAT)  ≥22),  or  uncontrolled
he  questionnaire  were  selected  with  the  help  of  groups  of
atients  and  physicians.  Initially,  26  questions  were  iden-
iﬁed,  separated  into  ﬁve  areas:  symptoms,  interference  in
ctivities,  limitations,  rhinitis  control,  and  medication  use.5
fter  application  to  a  large  group  of  patients,  this  initial
ersion  of  the  questionnaire  went  through  an  assessment
rocess  in  which  the  most  relevant  questions  were  identiﬁed
hrough  logistic  regression  analyses,  and  the  ﬁnal  version
omprised  six  questions.5
In  this  study,  some  important  properties  of  the  translated
ersion  of  RCAT  were  assessed.  The  reliability  was  evaluated
y  its  internal  consistency,  with  an  acceptable  value  (>0.7)
s  demonstrated  by  Cronbach’s  ˛  coefﬁcient.
In  the  constructive  validation,  the  overall  questionnaire
cores  (RCAT)  showed  a  strong  correlation  with  the  nasal
ymptom  score  (NSS).  The  correlation  coefﬁcient  found
−0.73)  was  higher  than  that  observed  when  the  original
ersion  of  RCAT  was  validated  (−0.57).6 Unlike  the  NSS,
he  RCAT  addresses  additional  aspects  besides  rhinitis  symp-
oms,  such  as  the  interference  of  rhinitis  with  sleep  and  daily
ctivities  and,  thus,  some  degree  of  disagreement  between
hese  tools  was  expected.  Differences  in  the  tools  are  more
arked  in  relation  to  the  ENSS  and  the  objective  mea-
urement  of  nasal  function  (PNIF).  Nevertheless,  moderate
orrelations  were  observed  between  them  (Fig.  2).
The  capacity  of  the  translated  version  of  RCAT  to  discrim-
nate  patients  according  to  the  degree  of  rhinitis  control  is
asily  observed  in  Figs.  3  and  4. These  ﬁgures  show  that  the
 and
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ﬁnal  scores  of  the  RCAT  are  clearly  different  when  patients
are  separated  by  the  medical  opinion  about  disease  control
or  the  severity  of  the  NSS.
The  identiﬁcation  of  the  best  RCAT  cutoff  to  discrimi-
nate  controlled  patients  from  those  with  problems  in  allergic
rhinitis  control  may  vary  according  to  the  purposes  and  aims
of  its  application,  and  it  is  possible  to  choose  cutoff  points
with  greater  sensitivity  or  greater  speciﬁcity.  In  the  origi-
nal  validation  of  RCAT,  the  cutoff  point  with  the  largest  area
under  the  ROC  curve  was  22  points  (AUC  =  0.689).  This  cutoff
point  also  showed  a  large  area  under  the  ROC  curve  in  the
validation  of  the  translated  version  (AUC  =  0.773;  Table  1).
When  this  cutoff  point  was  applied  to  the  group  of  studied
patients,  signiﬁcant  differences  were  observed  for  the  NSS,
ENSS,  and  PNIF  values  (Fig.  5).  Among  the  present  patients,
however,  the  cutoff  points  of  23  and  24  showed  larger  areas
under  the  ROC  curve,  particularly  due  to  the  biggest  gain  in
speciﬁcity  without  signiﬁcant  losses  in  sensitivity  (Table  1).
The  group  of  patients  evaluated  in  our  study  differed
in  some  aspects  from  the  group  evaluated  in  the  original
validation  of  RCAT;  the  most  relevant  aspects  were  the
age  group  and  the  diagnosis.  In  the  original  validation  of
RCAT,  only  patients  aged  18  years  or  older  could  partici-
pate,  whereas  the  present  study  included  only  adolescents
aged  12--18  years.  The  present  patients  had  persistent
allergic  rhinitis,  exclusively,  unlike  the  original  validation,
comprising  patients  with  perennial  allergic,  seasonal,  and
non-allergic  rhinitis.6
Further  studies  are  necessary  to  evaluate  other  proper-
ties  of  the  translated  version  of  RCAT,  already  studied  in
the  original  version  of  the  questionnaire,  such  as  its  repro-
ducibility  and  the  clinically  relevant  minimum  difference.
Conclusions
In  conclusion,  this  study  presented  a  version  of  the  RCAT
rhinitis  control  questionnaire  translated  into  the  Portuguese
language  (Brazilian  culture).  It  was  observed  that  this  ver-
sion  of  the  questionnaire  is  easily  understood  by  adolescents
with  allergic  rhinitis,  and  it  is  a  valid  tool  with  good  discrimi-
natory  power  to  differentiate  controlled  patients  from  those
non-controlled.
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